bioRxivCancer Biology
Structure and Functional Binding Epitope of V-domain Ig Suppressor of T-cell Activation (VISTA)
N. Mehta, S. Maddineni, I. I. Mathews, A. P. Sperberg, P.-S. Huang, J. R. Cochran
Abstract
V-domain Ig Suppressor of T cell Activation (VISTA) is an immune checkpoint protein that inhibits the T - cell response against cancer. Similar to PD-1 and CTLA-4, antibodies that block VISTA signaling can release the brakes of the immune system and promote tumor clearance. VISTA has an Ig-like fold, but little is known about its structure and mechanism of action. Here, we report a 1.85 [A] crystal structure of the human VISTA extracellular domain and highlight structural features that make VISTA unique among B7 family members. Through fine-epitope mapping, we also identify solvent-exposed residues that underlie binding to a clinically relevant anti-VISTA antibody. This antibody-binding region is also shown to interact with V-set and Ig domain-containing 3 (VSIG3), the recently proposed functional binding partner of VISTA. The structure and functional epitope determined here will help guide future drug development efforts against this important checkpoint target.
- organism: human
- assay: structural biology
- research focus: protein structure prediction
- research focus: cell-cell communication
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Membrane-coupled conformational switching of VISTA regulates immune checkpoint signaling via CC' loop accessibility
Aravindhan Ganesan, Varun Reddy, Norman Ly·bioRxiv·Feb 10, 2026
- On the same side: The immune regulatory protein Vista and its ligands interact in cis
Karina Smorodinsky-Atias, Gil Wiseglass, … Rotem Rubinstein·Protein SciencePeer-reviewed·Dec 22, 2025
- Expression of immune checkpoint VISTA represents a differentiated state of cancer cells and plays a role in regulating actin cytoskeleton
- VISTA-induced tumor suppression by a four amino acid intracellular motif
Yan Zhao, Tina Andoh, … Joshua James Gruber·bioRxiv·Jan 5, 2025
- Dual Targeting for Enhanced Tumor Immunity: Conditionally Active CD28xVISTA Bispecific Antibodies Promote Myeloid-Driven T-Cell Activation
Thomas Thisted, F. Donelson Smith, … Edward Htun van der Horst·bioRxiv·Apr 7, 2025
- Soluble CTLA-4 raises the threshold for T-cell activation and modulates anti-tumour immunity
P. T. Kennedy, E. L. Saulters, … L. N. Dahal·bioRxiv·Jun 5, 2023